The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

Atrasentan in Patients With Proteinuric Glomerular Diseases (AFFINITY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04573920
Recruitment Status : Active, not recruiting
First Posted : October 5, 2020
Last Update Posted : May 23, 2024
Information provided by (Responsible Party):
Chinook Therapeutics, Inc. ( Chinook Therapeutics U.S., Inc. )

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : July 31, 2024
Estimated Study Completion Date : July 28, 2026